MEDIPOST
Korea - Gyeonggi
BiotechnologyFocus: Stem cell technology & regenerative medicine
MEDIPOST is a life sciences company focused on Stem cell technology & regenerative medicine.
Cell Therapy
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
NEUROSTEM®-AD
Alzheimer DiseaseClinical Trials (1)
NCT01696591The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD
N/APneumostem®
Bronchopulmonary DysplasiaClinical Trials (1)
NCT01897987Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial
N/Aconditioned media of umbilical cord blood-derived stem cells
Androgenic AlopeciaClinical Trials (1)
NCT03676400Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia
N/APneumostem®
Bronchopulmonary DysplasiaClinical Trials (1)
NCT01632475Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia
N/Ahuman umbilical cord blood derived mesenchymal stem cells
Alzheimer's DiseaseClinical Trials (1)
NCT04954534Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM®
N/APNEUMOSTEM
Bronchopulmonary DysplasiaClinical Trials (1)
NCT02023788Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study
N/ASMUP-IA-01
Knee OsteoarthritisClinical Trials (1)
NCT04037345Evaluate Safety and Explore Efficacy of SMUP-IA-01 in Patients With Knee Osteoarthritis
Phase 1Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells
Bronchopulmonary DysplasiaClinical Trials (1)
NCT01297205Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia
Phase 1SMUP-IA-01
Knee OsteoarthritisClinical Trials (1)
NCT04339504Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial
Phase 1Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells
Dementia of the Alzheimer's TypeClinical Trials (1)
NCT01297218The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease
Phase 1CARTISTEM®
Degeneration Articular Cartilage KneeClinical Trials (1)
NCT01733186Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects
Phase 1/2Human umbilical cord blood-derived mesenchymal stem cells
Graft-Versus-Host DiseaseClinical Trials (1)
NCT01549665Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease
Phase 1/2human umbilical cord blood derived mesenchymal stem cells
Alzheimer's DiseaseClinical Trials (1)
NCT02054208Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease
Phase 1/2human umbilical cord blood derived mesenchymal stem cells
Alzheimer's DiseaseClinical Trials (1)
NCT03172117Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.
Phase 1/2Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells
Bronchopulmonary DysplasiaClinical Trials (1)
NCT02381366Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study
Phase 1/2Human umbilical cord blood-derived mesenchymal stem cells
Acute LeukemiaClinical Trials (1)
NCT00823316Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation
Phase 1/2PNEUMOSTEM
Severe Bronchopulmonary DysplasiaClinical Trials (1)
NCT03392467PNEUMOSTEM for the Prevention and Treatment of Severe BPD in Premature Infants
Phase 2Pneumostem®
Bronchopulmonary DysplasiaClinical Trials (1)
NCT01828957Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of BPD in Premature Infants
Phase 2PNEUMOSTEM®
Bronchopulmonary DysplasiaClinical Trials (1)
NCT04003857Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial
Phase 2SMUP-IA-01
Knee OsteoarthritisClinical Trials (1)
NCT06798727Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control
Phase 2SMUP-IA-01
Knee OsteoarthritisClinical Trials (1)
NCT05182034Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis
Phase 2Cartistem
Cartilage InjuryClinical Trials (1)
NCT01041001Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury
Phase 3Phase 3
Clinical Trials (1)
NCT04310215Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM®) for Osteochondral Lesion of Talus
Phase 3CARTISTEM® + Debridement
Knee Cartilage DefectsClinical Trials (1)
NCT07339111Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Phase 3CARTISTEM
Degenerative OsteoarthritisClinical Trials (1)
NCT01626677Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 25 clinical trials